Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
University of California San Francisco-Benioff Children's Hospital, San Francisco, California Children's Hospital Colorado, Aurora, Colorado Children's Healthcare of Atlanta at Arthur M. Blank Hospital, Atlanta, Georgia Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois Dana-Farber Cancer Institute, Boston, Massachusetts